Epstein-Barr virus-associated lymphoproliferative disorder
MONDO:0017343A range of lymphoproliferative diseases characterized by uncontrolled proliferation of B cells, T cells, or NK cells infected with Epstein-Barr virus. Depending on host immunity and viral factors, viral persistence in host cells can induce lymphoproliferation with a diverse clinical spectrum ranging from simple reactive hyperplasia to aggressive lymphoma/leukemia with unique clinical and pathological presentations.
Also known as: EBV-associated lymphoproliferative disorder, Epstein-Barr virus-associated malignant lymphoproliferative disorder
2141 clinical trials for this condition and its sub-types, 22 tagged with Epstein-Barr virus-associated lymphoproliferative disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Epstein-Barr virus-associated lymphoproliferative disorder
-
Hodgkins lymphoma 262 trials · 326 incl. sub-types
5 sub-types
- Classic Hodgkin lymphoma 147 trials · 149 incl. sub-types Sub-types →
- Nodular lymphocyte predominant Hodgkin lymphoma 5 trials · 6 incl. sub-types Sub-types →
- Lymphoma, Hodgkin, X-linked pseudoautosomal 0 trials
- Lymphoma, Hodgkin, Y-linked pseudoautosomal 0 trials
- Splenic hodgkin lymphoma 0 trials
-
Burkitt lymphoma 221 trials
2 sub-types
- Colon Burkitt lymphoma 0 trials
- Small intestinal Burkitt lymphoma 0 trials
-
Primary central nervous system lymphoma 92 trials · 103 incl. sub-types
3 sub-types
- Central nervous system non-hodgkin lymphoma 1 trial · 22 incl. sub-types Sub-types →
- Cerebral lymphoma 2 trials
- Spinal cord lymphoma 0 trials
-
Extranodal nasal NK/T cell lymphoma 51 trials
-
Plasmablastic lymphoma 20 trials
-
Primary effusion lymphoma 18 trials
-
Lymphomatoid granulomatosis 3 trials · 7 incl. sub-types
3 sub-types
- Grade III lymphomatoid granulomatosis 4 trials
- Grade I lymphomatoid granulomatosis 0 trials
- Grade II lymphomatoid granulomatosis 0 trials
-
Hydroa vacciniforme-like lymphoma 3 trials
Most studied deeper sub-types
-
One Patient's lifeline: donor t cells take on EBV lymphoma
Disease control CompletedThis study tested a personalized treatment for a young adult with a severe EBV-related lymphoma that occurred after a stem cell transplant. The patient received up to four infusions of specially grown immune cells from their original stem cell donor. The goal was to see if these …
Sponsor: Ciusss de L'Est de l'Île de Montréal • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study aims to crack the code of autoimmune diseases
Knowledge-focused CompletedThis study is collecting blood, urine, and stool samples from 500 children with autoimmune diseases and healthy controls. Researchers will analyze these samples to find molecular patterns that could help diagnose these conditions and guide treatment decisions. The goal is to crea…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Virus tracking in kidney transplants may spot hidden risks
Knowledge-focused CompletedThis study followed 509 kidney transplant recipients to see if regularly measuring Epstein-Barr virus (EBV) levels in blood could predict serious infections, a type of cancer called PTLD, or death. Researchers compared virus levels in whole blood versus plasma to find the best wa…
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC